levodopa

Showing 1 posts of 1 posts found.

Trial failure for Merck Serono’s Parkinson’s candidate

November 8, 2010
Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide

Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …

The Gateway to Local Adoption Series

Latest content